(Q33718831)

28 July 2017

1 reference

title

Monoclonal antibody-directed cytotoxic therapy: potential in malignant diseases of aging (English)

1 reference

28 July 2017

Panousis C

1

1 reference

28 July 2017

Pietersz GA

series ordinal

2

1 reference

28 July 2017

publication date

1 July 1999

1 reference

28 July 2017

1 reference

28 July 2017

volume

15

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

1-13

1 reference

The human immune response to KS1/4-desacetylvinblastine (LY256787) and KS1/4-desacetylvinblastine hydrazide (LY203728) in single and multiple dose clinical studies

28 July 2017

cites work

1 reference

12 December 2020

Radioimmunotherapy for breast cancer using indium-111/yttrium-90 BrE-3: results of a phase I clinical trial

1 reference

12 December 2020

Phase I evaluation of a combination of monoclonal antibody R24 and interleukin 2 in patients with metastatic melanoma

1 reference

12 December 2020

Pilot trial of murine monoclonal antibodies in patients with advanced melanoma

1 reference

12 December 2020

Phase I trial of mitomycin C immunoconjugates cocktails in human malignancies

1 reference

12 December 2020

A phase-I study of an anti-CD25 ricin A-chain immunotoxin (RFT5-SMPT-dgA) in patients with refractory Hodgkin's lymphoma

1 reference

12 December 2020

Biodistribution of iodine-125 labeled monoclonal antibody/interleukin-2 immunoconjugate in athymic mice bearing human tumor xenografts

1 reference

12 December 2020

Therapeutic index: a vital component in selection of anticancer agents for clinical trial

1 reference

12 December 2020

Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody

1 reference

12 December 2020

Tumors undergoing rejection induced by monoclonal antibodies of the IgG2a isotype contain increased numbers of macrophages activated for a distinctive form of antibody-dependent cytolysis

1 reference

12 December 2020

[Effect on mouse leukemia 1210 of a combination by diazo-reaction of amethopterin and gamma-globulins from hamsters inoculated with such leukemia by heterografts.]

1 reference

12 December 2020

Systemic induction of cells mediating antibody-dependent cellular cytotoxicity following administration of interleukin 2

1 reference

12 December 2020

Phase I trial of H65-RTA immunoconjugate in patients with cutaneous T-cell lymphoma

1 reference

12 December 2020

Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01

1 reference

12 December 2020

Phase I clinical trial of drug-monoclonal antibody conjugates in patients with advanced colorectal carcinoma: a preliminary report

1 reference

12 December 2020

Novel synthesis and in vitro characterization of disulfide-linked ricin-monoclonal antibody conjugates devoid of galactose binding activity

1 reference

12 December 2020

Synergistic antitumor effects of interleukin 2 and the monoclonal Lym-1 against human Burkitt lymphoma cells in vitro and in vivo.

1 reference

12 December 2020

Biological and antitumor effects of recombinant human macrophage colony-stimulating factor in mice

1 reference

12 December 2020

Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate

1 reference

12 December 2020

Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer

1 reference

12 December 2020

Phase-I/II radio-immunotherapy study with Iodine-131-labeled anti-CEA monoclonal antibody F6 F(ab')2 in patients with non-resectable liver metastases from colorectal cancer

1 reference

12 December 2020

Antimelanoma monoclonal antibody-ricin A chain immunoconjugate (XMMME-001-RTA) plus cyclophosphamide in the treatment of metastatic malignant melanoma: results of a phase II trial.

1 reference

12 December 2020

Prospects of radioimmunotherapy in epithelial ovarian cancer: results with iodine-131-labeled murine and humanized MN-14 anti-carcinoembryonic antigen monoclonal antibodies

1 reference

12 December 2020

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.

1 reference

12 December 2020

Anti-tumour activity of aminopterin-monoclonal antibody conjugates; in vitro and in vivo comparison with methotrexate-monoclonal antibody conjugates

1 reference

12 December 2020

Combination therapy with interleukin-2 and antitumor monoclonal antibodies.

1 reference

12 December 2020

Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2

1 reference

12 December 2020

Phase I clinical comparative study of monoclonal antibody KS1/4 and KS1/4-methotrexate immunconjugate in patients with non-small cell lung carcinoma

1 reference

12 December 2020

Increased survival associated with radiolabeled Lym-1 therapy for non-Hodgkin's lymphoma and chronic lymphocytic leukemia

1 reference

12 December 2020

Clinical and immunological studies in advanced cancer patients sequentially treated with anti CD3 monoclonal antibody (OKT3) and interleukin-2

1 reference

12 December 2020

Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.

1 reference

12 December 2020

Comparative toxicity studies of yttrium-90 MX-DTPA and 2-IT-BAD conjugated monoclonal antibody (BrE-3).

1 reference

12 December 2020

Intratumor localization of monoclonal antibody in patients with melanoma treated with antibody to a 250,000-dalton melanoma-associated antigen

1 reference

12 December 2020

Antibody-based immunotherapeutic strategies in colorectal cancer.

1 reference

12 December 2020

Intraperitoneal radioimmunotherapy of ovarian cancer with 177Lu-CC49: a phase I/II study

1 reference

12 December 2020

Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody

1 reference

12 December 2020

Calicheamicin gamma 1I: an antitumor antibiotic that cleaves double-stranded DNA site specifically

1 reference

12 December 2020

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support

1 reference

12 December 2020

Adriamycin custom-tailored immunoconjugates in the treatment of human malignancies.

1 reference

12 December 2020

Engineering Antibodies for Therapy

1 reference

12 December 2020

Phase I immunotoxin trial in patients with B-cell lymphoma

1 reference

12 December 2020

The biologic effects of C225, a chimeric monoclonal antibody to the EGFR, on human prostate carcinoma

1 reference

12 December 2020

Stable bifunctional chelates of metals used in radiotherapy

1 reference

12 December 2020

Intraventricular immunotoxin therapy for leptomeningeal neoplasia

1 reference

12 December 2020

Radioimmunotherapy of patients with small-volume tumors using iodine-131-labeled anti-CEA monoclonal antibody NP-4 F(ab')2.

1 reference

12 December 2020

Phase I Study of an Anti-Breast Cancer Immunotoxin by Continuous Infusion: Report of a Targeted Toxic Effect Not Predicted by Animal Studies

1 reference

12 December 2020

Treatment of advanced solid tumors with immunotoxin LMB-1: an antibody linked to Pseudomonas exotoxin

1 reference

12 December 2020

Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations

1 reference

12 December 2020

Surface immunoglobulin of B-lymphocytic tumours as a therapeutic target

1 reference

12 December 2020

Intraperitoneal yttrium-90-labeled monoclonal antibody in ovarian cancer

1 reference

12 December 2020

Evaluation of therapeutic response using iodine-131-B72.3 monoclonal antibody in patients with ovarian carcinoma

1 reference

12 December 2020

Trends in cancer mortality in 15 industrialized countries, 1969-1986.

1 reference

12 December 2020

Antibody dependent cell-mediated cytotoxicity induced by chimeric mouse-human IgG subclasses and IgG3 antibodies with altered hinge region

1 reference

12 December 2020

Serotherapy of acute lymphoblastic leukemia with monoclonal antibody.

1 reference

12 December 2020

Anti-renal-cell carcinoma chimeric antibody G250 facilitates antibody-dependent cellular cytotoxicity with in vitro and in vivo interleukin-2-activated effectors

1 reference

12 December 2020

Clinical application of monoclonal antibody-drug conjugates for immunotargeting chemotherapy of colorectal carcinoma

1 reference

12 December 2020

In vitro antitumor activity of 2'-deoxy-5-fluorouridine-monoclonal antibody conjugates

1 reference

12 December 2020

Antibody conjugates for the treatment of cancer

1 reference

12 December 2020

Individually specified drug immunoconjugates in cancer treatment

1 reference

12 December 2020

Single-dose murine monoclonal antibody ricin A chain immunotoxin in the treatment of metastatic melanoma: a phase I trial

1 reference

12 December 2020

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

1 reference

12 December 2020

Phase-I clinical trial of monoclonal antibody in treatment of gastrointestinal tumours

1 reference

12 December 2020

A phase I study of bolus versus continuous infusion of the anti-CD19 immunotoxin, IgG-HD37-dgA, in patients with B-cell lymphoma.

1 reference

12 December 2020

Continuous cultures of fused cells secreting antibody of predefined specificity

1 reference

12 December 2020

Response of cutaneous T cell lymphoma to therapy with hybridoma monoclonal antibody

1 reference

12 December 2020

Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer.

1 reference

12 December 2020

The in vivo release of 90Y from cyclic and acyclic ligand-antibody conjugates

1 reference

12 December 2020

New trends in the use of radioimmunoconjugates for the therapy of cancer

1 reference

12 December 2020

The linkage of cytotoxic drugs to monoclonal antibodies for the treatment of cancer

1 reference

12 December 2020

Murine monoclonal antibody therapy in two patients with chronic lymphocytic leukemia

1 reference

12 December 2020

Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferon

1 reference

12 December 2020

Preparation and preclinical evaluation of humanised A33 immunoconjugates for radioimmunotherapy.

1 reference

12 December 2020

Human monoclonal antibody to tumor-associated ganglioside GD2: suppressed growth of human melanoma in nude mice

1 reference

12 December 2020

Phase I study of monoclonal antibody-ricin A chain immunoconjugate Xomazyme-791 in patients with metastatic colon cancer.

1 reference

12 December 2020

Specific targeting of chlorambucil to tumors with the use of monoclonal antibodies

1 reference

12 December 2020

Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancer

1 reference

12 December 2020

Two distinct mechanisms of antitumor activity mediated by the combination of interleukin 2 and monoclonal antibodies

1 reference

12 December 2020

Biological approaches to the controlled delivery of drugs: a critical review.

1 reference

12 December 2020

An immunotoxin prepared with blocked ricin: a natural plant toxin adapted for therapeutic use

1 reference

12 December 2020

10.2165/00002512-199915010-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1043652144

0 references

1 reference